1-Methoxyindole-3-carboxylic acidCAS# 91913-76-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 91913-76-7 | SDF | Download SDF |
PubChem ID | 124476 | Appearance | Powder |
Formula | C10H9NO3 | M.Wt | 191.2 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1-methoxyindole-3-carboxylic acid | ||
SMILES | CON1C=C(C2=CC=CC=C21)C(=O)O | ||
Standard InChIKey | NYXZLEZAQMDQPX-UHFFFAOYSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Standard reference |
In vitro | In vitro O-demethylation from a heterocyclic nitrogen: a novel metabolic reaction?[Pubmed: 1949889]Xenobiotica. 1991 May;21(5):569-74.
|
1-Methoxyindole-3-carboxylic acid Dilution Calculator
1-Methoxyindole-3-carboxylic acid Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.2301 mL | 26.1506 mL | 52.3013 mL | 104.6025 mL | 130.7531 mL |
5 mM | 1.046 mL | 5.2301 mL | 10.4603 mL | 20.9205 mL | 26.1506 mL |
10 mM | 0.523 mL | 2.6151 mL | 5.2301 mL | 10.4603 mL | 13.0753 mL |
50 mM | 0.1046 mL | 0.523 mL | 1.046 mL | 2.0921 mL | 2.6151 mL |
100 mM | 0.0523 mL | 0.2615 mL | 0.523 mL | 1.046 mL | 1.3075 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 19-[(beta-D-glucopyranosyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide
Catalog No.:BCN1308
CAS No.:919120-78-8
- GPi 688
Catalog No.:BCC6091
CAS No.:918902-32-6
- TH-302
Catalog No.:BCC1998
CAS No.:918633-87-1
- PLX-4720
Catalog No.:BCC1280
CAS No.:918505-84-7
- BRAF inhibitor
Catalog No.:BCC1436
CAS No.:918505-61-0
- Vemurafenib (PLX4032, RG7204)
Catalog No.:BCC1269
CAS No.:918504-65-1
- 5,7,4'-Trimethoxyafzelechin
Catalog No.:BCN7933
CAS No.:918428-88-3
- Cefdinir
Catalog No.:BCC3747
CAS No.:91832-40-5
- UCL 2077
Catalog No.:BCC7446
CAS No.:918311-87-2
- MK-6892
Catalog No.:BCC1767
CAS No.:917910-45-3
- MK-2461
Catalog No.:BCC3816
CAS No.:917879-39-1
- CCMI
Catalog No.:BCC7788
CAS No.:917837-54-8
- Atrial natriuretic factor (1-28) (human, porcine)
Catalog No.:BCC5839
CAS No.:91917-63-4
- Ro 15-4513
Catalog No.:BCC7230
CAS No.:91917-65-6
- Rubrisandrin A
Catalog No.:BCN3248
CAS No.:919289-30-8
- AZD1283
Catalog No.:BCC5370
CAS No.:919351-41-0
- Zatebradine hydrochloride
Catalog No.:BCC7286
CAS No.:91940-87-3
- Buergerinin B
Catalog No.:BCN4555
CAS No.:919769-83-8
- Saikosaponin H
Catalog No.:BCN7808
CAS No.:91990-63-5
- OF-1
Catalog No.:BCC5579
CAS No.:919973-83-4
- o-Acetoacetaniside
Catalog No.:BCC9107
CAS No.:92-15-9
- 6-Methylcoumarin
Catalog No.:BCN6906
CAS No.:92-48-8
- Scopoletin
Catalog No.:BCN4470
CAS No.:92-61-5
- Phenothiazine
Catalog No.:BCC4701
CAS No.:92-84-2
In vitro O-demethylation from a heterocyclic nitrogen: a novel metabolic reaction?[Pubmed:1949889]
Xenobiotica. 1991 May;21(5):569-74.
1. O-Demethylation of 1-Methoxyindole-3-carboxylic acid, in vitro, by determination of liberated formaldehyde, has been demonstrated using fortified 15,000 g rat liver supernatant fraction. 2. Results have been compared to those similarly obtained with a standard O-demethylation substrate, 4-nitroanisole, to substantiate and quantify the extent of the reaction. 3. Km values for 4-nitroanisole and methoxyindole-3-carboxylic acid were 8.9 and 6.5 mM, while Vmax values were 4.9, and 5.2 nmol HCHO produced/mg protein per min. 4. The significance of the metabolic O-demethylation reaction for N-methoxyindoles as a novel metabolic pathway is discussed in terms of pharmacological activity and biological reactivity.